Nasdaq Markets

The stock market had a great run in the 2010s, but 2020 has already reminded us that crashes do happen -- and that they're pretty unpleasant. A sudden 30% drop in the value of your long-term savings can reverse years of contributions and investment growth, putting your retiremen

Gilead Sciences (NASDAQ: GILD) has been at the forefront of the coronavirus treatment space since the early days of the pandemic. During this past spring and early summer, the company donated almost a million doses of its antiviral medication, remdesivir, to the U.S. government

Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC) are two of the bigger names in the cannabis industry. They're both facing similar challenges -- namely, how to keep growing amid rising competition while also getting closer to breakeven. Within the past 14 months, bot

Inovio Pharmaceuticals (NASDAQ: INO) has enjoyed a remarkable year so far by any standard. The biotech is in the thick of the race to develop a COVID-19 vaccine. It has made significant progress with its other pipeline candidates. Inovio's shares have skyrocketed close to 350%.

Which of Pfizer's (NYSE: PFE) products grab investors' attention the most? I'd put BNT162b2, the COVID-19 vaccine candidate that Pfizer is developing with BioNTech, high on the list. The company's top-selling drugs Ibrance and Eliquis would also certainly make the cut. Pneumoco

Former Indian Prime Minister Indira Gandhi once said, "Popularity is not a guarantee of quality." She was exactly right. And her statement is applicable to investing as much as it is anything else.

If you're retired (or close to that point), there are typically two main things you'll look for in stocks. First, the stock should pay an attractive dividend. Second, the underlying business should be solid and reliable. 

Being an investor in 2020 hasn't been easy. The uncertainty and panic created by the coronavirus disease 2019 (COVID-19) pandemic initially sent equities to their steepest bear-market tailspin in history. This was followed by one of the strongest quarterly rallies in a decade. E

Machine vision company Cognex Corporation (NASDAQ: CGNX) has had a difficult year, but somehow the stock is up nearly 17% at the time of writing. What's going on, and has the rally in the share price got ahead of itself in the last few months? Let's take a closer look.

The COVID-19 pandemic has challenged many smaller companies. Investors who favor stocks below $2 billion in market capitalization for growth potential are probably wondering if it's safe to put new money there with so many uncertainties about how the pandemic is going to play ou

Before the COVID-19 crisis, many people worked remotely by choice. Now, countless workers are performing their jobs from home or other off-site locations involuntarily -- whether because it's unsafe to go into an office, there are few child care options, or both. Some workers ar

To the long list of COVID-19's business victims, you can add dividend stocks.

COVID-19 did a number on the stock market -- several numbers, in fact.

This has been a crazy year. The coronavirus disease 2019 (COVID-19) pandemic has upended societal norms, pushed the unemployment rate to levels not seen since the 1930s, and tragically cost the lives of more than 160,000 Americans.

Image source: Getty Images

The International Monetary Fund called the global response to COVID-19 the "Great Lockdown" -- and it's a label that should strike fear into the hearts of investors in hotel stocks like Hilton Worldwide (NYSE: HLT).  

Banking on Social Security to pay your bills in retirement? That's a risky move for at least two reasons. One, for most people, Social Security replaces about 40% of your working income -- which won't fund your current lifestyle. And two, the federal response to the coronavirus

Upscale hotel franchisor Marriott International (NASDAQ: MAR) illustrated its ability to grind out a protracted recovery from the COVID-19 pandemic in its second quarter 2020 earnings released on Aug. 10. But exactly when the hospitality giant will see anything close to former p

Opening up Central Florida's theme parks after months of inactivity wasn't easy. Scaling back operations now that demand is falling short of expectations will be even harder. 

Amazon (NASDAQ: AMZN) has been one of the undisputed beneficiaries of the lockdowns that have blanketed much of the country -- and even the world -- since the COVID-19 pandemic began. Consumers turned to e-commerce in accelerating numbers to avoid leaving home for fear of contra